En Carta Diagnostics

En Carta Diagnostics

DeepTechMolecular DiagnosticsB2C📍 Paris, France

En Carta Diagnostics is a Paris-based deeptech startup focused on developing home-based molecular diagnostic tools for Lyme disease and sexually transmitted infections. The company aims to provide results within 30 minutes, matching the precision of laboratory PCR tests, and has recently achieved FDA Breakthrough Device Designation.

Total raised
$5.3M
tracked to date
Latest round
$5.3M
Jul 12, 2026
Known investors
5
led by Blue Forest Ventures

Is this your company?

Claim this profile to get matched with investors who fund DeepTech startups in France.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 France Funding Report

Read the Q3 2026 France report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-france-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 France Funding Report</a>

Funding history

  1. 1
    $5.3MJul 12, 2026

    Led by Blue Forest Ventures

    Announcement ↗

Founder

Guillaume Horreard
Guillaume Horreard
Co-founder

Investors in En Carta Diagnostics

Backers from this company's tracked funding rounds.

  • BBlue Forest VenturesLead investorVC firm
  • RRing CapitalVC firm
  • CCentraleSupélec VentureVC firm
  • 550 Partners HealthVC firm
  • BBpifranceVC firm

En Carta Diagnostics in the news

Coverage of this company's funding, tracked by Datapile.

More DeepTech companies

Recently funded startups in the same category.

Related on Datapile

En Carta Diagnostics — DeepTech startup in Paris, France | Datapile